A carregar...
An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer’s Disease
BACKGROUND: T3D-959 is a chemically unique, brain penetrant, dual PPAR delta/gamma agonist with 15-fold higher PPAR delta selectivity. Ubiquitous brain expression of PPAR delta, its critical role in regulating glucose and lipid metabolism, and the Alzheimer’s disease (AD)-like phenotype of PPAR delt...
Na minha lista:
Publicado no: | J Alzheimers Dis |
---|---|
Main Authors: | , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
IOS Press
2020
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7081093/ https://ncbi.nlm.nih.gov/pubmed/31884472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-190864 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|